Pathogenesis of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Accessory Protein Open Reading Frame 7b (Orf7b) in Thymus-cell (T-cell) Lymphopenia

被引：0
|
作者：
Deshpande, R. [1 ]
Li, W. [2 ]
Zou, C. [2 ]
机构：
[1] Univ Pittsburgh, Environm & Occupat Hlth, Sch Publ Hlth, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6295
引用
收藏
页数：1
相关论文
共 48 条
  • [41] Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
    Hensley, Matthew K.
    Bain, William G.
    Jacobs, Jana
    Nambulli, Sham
    Parikh, Urvi
    Cillo, Anthony
    Staines, Brittany
    Heaps, Amy
    Sobolewski, Michele D.
    Rennick, Linda J.
    Macatangay, Bernard J. C.
    Klamar-Blain, Cynthia
    Kitsios, Georgios D.
    Methe, Barbara
    Somasundaram, Ashwin
    Bruno, Tullia C.
    Cardello, Carly
    Shan, Feng
    Workman, Creg
    Ray, Prabir
    Ray, Anuradha
    Lee, Janet
    Sethi, Rahil
    Schwarzmann, William E.
    Ladinsky, Mark S.
    Bjorkman, Pamela J.
    Vignali, Dario A.
    Duprex, W. Paul
    Agha, Mounzer E.
    Mellors, John W.
    McCormick, Kevin D.
    Morris, Alison
    Haidar, Ghady
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E815 - E821
  • [42] Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report
    Nilius-Eliliwi, Verena
    Mika, Thomas
    Baraniskin, Alexander
    Wuennenberg, Max
    Maslova, Marina
    Boy, Christian
    Klein-Scory, Susanne
    Schroers, Roland
    Vangala, Deepak
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine
    Kobashi, Yurie
    Shimazu, Yuzo
    Kawamura, Takeshi
    Nishikawa, Yoshitaka
    Omata, Fumiya
    Kaneko, Yudai
    Kodama, Tatsuhiko
    Tsubokura, Masaharu
    PLOS ONE, 2022, 17 (06):
  • [44] T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
    Blixt, Lisa
    Wullimann, David
    Aleman, Soo
    Lundin, Jeanette
    Chen, Puran
    Gao, Yu
    Cuapio, Angelica
    Akber, Mira
    Lange, Joshua
    Rivera-Ballesteros, Olga
    Buggert, Marcus
    Ljunggren, Hans-Gustaf
    Hansson, Lotta
    Osterborg, Anders
    HAEMATOLOGICA, 2022, 107 (04) : 1000 - 1003
  • [45] PHASE 1/2 STUDY OF AGENT-797, AN ALLOGENEIC INVARIANT NATURAL KILLER T (INKT) CELL THERAPY, IN SUBJECTS WITH MODERATE TO SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SECONDARY TO SARS-COV-2 (COVID-19)
    Purbhoo, Marco
    Yigit, Burcu
    Michelet, Xavier
    Smith, Rachel
    Moskowitz, Darrian
    Kirby, Maurice
    Buffa, Alexa
    De Munari, Sonia
    Feliu, Waldo Ortuzar
    Van Besien, Koen
    Stevens, Don
    Exley, Mark
    Hammond, Terese
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A680 - A680
  • [46] COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
    Garcia-Arriaza, Juan
    Garaigorta, Urtzi
    Perez, Patricia
    Lazaro-Frias, Adrian
    Zamora, Carmen
    Gastaminza, Pablo
    Del Fresno, Carlos
    Casasnovas, Jose M.
    Sorzano, Carlos Oscar S.
    Sancho, David
    Esteban, Mariano
    JOURNAL OF VIROLOGY, 2021, 95 (07)
  • [47] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells
    Manfredelli, Dominga
    Pariano, Marilena
    Costantini, Claudio
    Graziani, Alessandro
    Bozza, Silvia
    Romani, Luigina
    Puccetti, Paolo
    Talesa, Vincenzo Nicola
    Antognelli, Cinzia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [48] Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
    Prakash, Swayam
    Dhanushkodi, Nisha R.
    Zayou, Latifa
    Ibraim, Izabela Coimbra
    Quadiri, Afshana
    Coulon, Pierre Gregoire
    Tifrea, Delia F.
    Suzer, Berfin
    Shaik, Amin Mohammed
    Chilukuri, Amruth
    Edwards, Robert A.
    Singer, Mahmoud
    Vahed, Hawa
    Nesburn, Anthony B.
    Kuppermann, Baruch D.
    Ulmer, Jeffrey B.
    Gil, Daniel
    Jones, Trevor M.
    BenMohamed, Lbachir
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345